The Top 10 Highest-Paid Women Executives in Biopharma
Compensation Has Climbed since 2014, yet Gap with Male Counterparts Remains
Supplement: CRISPR Enters the Clinic
Using CRISPR-Altered Cells to Fight Disease
The Scoop: CRISPR Patent Case Argued Before Appeals Court
Final Verdict Could Impact Future Research and Funding
Supplement: Pushing the Boundaries of CRISPR
Innovations in Genome Editing on Multiple Fronts
Audrey Chang Ph.D.
Audrey Chang, Ph.D., serves as head of development services, at the BioReliance® portfolio of MilliporeSigma.